REDHILL BIOPHARMA LTD.

Codice
RDHL
Risorse esterne
Opinione della community
Prezzo Variazione Volume
9.63 -2.53 €
(-20.81%)
31653
P/E Obiettivo ad 1anno
0 31.67 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 19
Sell : 9

Riky3695 Marco Di Folco AngerManagement Imperator Antonio Peluso Sipra boss66 Vlad Alexandru Cerbero Demi9996

Commenti


Notizie

RedHill Biopharma Ltd – (RDHL) Stake Held by Orbimed Advisors ... - Sports Perspectives

Orbimed Advisors LLC maintained its position in shares of RedHill Biopharma Ltd – (NASDAQ:RDHL) during the fourth quarter, according to its most recent 13F ... Leggi

Stock's Move to Focus: SandRidge Permian Trust (NYSE:PER) , Redhill Biopharma Ltd. (NASDAQ:RDHL) - NYSE Journal (press release)

On 2/17/2017, Shares of SandRidge Permian Trust (NYSE:PER) closed at $3.20 in last trading day. After noting the initial trading entry at $3.25, it reached to a day's high of $3.30 and moved to a day's low of $3.20. The recent daily volume was 105.95 ...altro » Leggi

RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) has been downgraded to Hold in a report by Zacks Investment ... - Breaking Finance News

Yesterday RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) traded -0.41% lower at $9.81. The company's 50-day moving average is $10.13 and its 200-day moving average is $12.62. The last stock close price is down -22.25% from the 200-day moving ...altro » Leggi

20 Stocks Moving In Monday's Pre-Market Session - Benzinga

RedHill Biopharma Ltd - ADR (NASDAQ: RDHL) fell 5.2 percent to $9.72 in pre-market trading after rising 0.79 percent on Friday. Dynavax Technologies Corporation (NASDAQ: DVAX) fell 4.7 percent to $4.05 in pre-market trading after gaining 1.19 percent ...altro » Leggi

The Zacks Analyst Blog Highlights: Celgene, Exelixis, Ligand Pharmaceuticals and RedHill Biopharma - Yahoo Finance

Stocks recently featured in the blog include Celgene Corporation (NASDAQ:CELG – Free Report ) , Exelixis, Inc. (NASDAQ:EXEL – Free Report ) , Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report ) and RedHill Biopharma Ltd. ... Moreover ... Leggi

APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance - Nasdaq

CDTX closed Tuesday's trading at $7.20, down 38.46%. ... RedHill Biopharma Ltd. ( RDHL ) has completed treatment of the last patient enrolled in its Phase III study of BEKINDA 24 mg for the treatment of acute gastroenteritis and gastritis. The study ...altro » Leggi

Redhill Biopharma Ltd. (RDHL) Under Analyst Spotlight - UK Market News

Amid volatile financial markets and the presidential election, various investment brokerages have made amendments to their price targets and ratings on shares of Redhill Biopharma Ltd. (RDHL). Based on the latest brokerage notes which have been ... Leggi

Redhill Biopharma Ltd. - Receive News & Ratings Daily - BBNS

Shares of Redhill Biopharma (NASDAQ:RDHL) traded up 1.61% during midday trading on Thursday, hitting $9.48. 51,296 shares of the company's stock traded hands. The stock's market cap is $120.84 million. The company has a 50 day moving average of ... Leggi

Redhill Biopharma Ltd. (RDHL) Reviewed By Analysts - The De Soto Edge

Stock market analysts watching Redhill Biopharma Ltd. (RDHL) have recently changed their ratings on the stock. The latest reports which are outstanding on Monday 6th of February state 1 analyst has a rating of “strong buy”, 3 analysts “buy”, 0 analysts ... Leggi

Zacks Investment Research Upgrades REDHILL BIO-ADR (RDHL) to “Buy” - BBNS

REDHILL BIO-ADR logo REDHILL BIO-ADR (NASDAQ:RDHL) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a research report issued to clients and investors on Thursday. The brokerage presently has a $12.00 target ...altro » Leggi